Status:
UNKNOWN
Functional Neuroimaging in Fibromyalgia Patients Receiving tDCS
Lead Sponsor:
Hospital de Clinicas de Porto Alegre
Conditions:
Fibromyalgia
Chronic Pain
Eligibility:
FEMALE
18-65 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to evaluate effectiveness and cerebral neuronal ability to adaptation in patients with fibromyalgia who receive pregabalin and transcranial direct current stimulation.
Detailed Description
Fibromyalgia syndrome occurs in around 2% of the population (predominantly women), and is characterized by its poor response to conventional therapies. Therapeutic approaches modulating inhibitory pat...
Eligibility Criteria
Inclusion
- \- Diagnosis of fibromyalgia according to the American College of Rheumatology criteria
Exclusion
- Psychiatric or neurologic disorder that unable patient to consent and follow study protocol.
- De-compensated systemic disease.
- Chronic inflammatory disease (e.g. Systemic Lupus Erythematous, Rheumatoid Arthritis).
Key Trial Info
Start Date :
March 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2014
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT01904097
Start Date
March 1 2013
End Date
December 1 2014
Last Update
July 22 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital de Clínicas de Porto Alegre
Porto Alegre, Rio Grande do Sul, Brazil, 90035-903